Active Shortage

MOVAPO

PALADIN LABS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MOVAPO in Canada?

Yes. MOVAPO 10MG has an active shortage reported to Health Canada (last updated October 16, 2023).

Why is MOVAPO not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MOVAPO be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength10MG

Report last updated2023-10-16

Checked by MedShort2026-11-13

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02459132

Strength

10MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

APOMORPHINE HYDROCHLORIDE

Tier

Unrated

Last Updated

2023-10-16

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗